{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:52Z","timestamp":1787032852665,"version":"build-2736575974"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,24]]},"DOI":"10.7759\/cureus.31871","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:02:01Z","timestamp":1669334521000},"source":"Crossref","is-referenced-by-count":1,"title":["Statin-Induced Myositis with Concomitant Myocarditis"],"prefix":"10.7759","author":[{"given":"Haris","family":"Patail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya","family":"Nadig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Kunkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.15450","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement","volume":"316","author":"Bibbins-Domingo K","year":"2016","unstructured":"Bibbins-Domingo K, Grossman DC, Curry SJ, et al.. Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement. JAMA. 2016, 316:1997-2007. 10.1001\/jama.2016.15450","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15739-5","article-title":"Selenoprotein synthesis and side-effects of statins","volume":"363","author":"Moosmann B","year":"2004","unstructured":"Moosmann B, Behl C. Selenoprotein synthesis and side-effects of statins. Lancet. 2004, 363:892-4. 10.1016\/S0140-6736(04)15739-5","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.6515\/acs20160611a","article-title":"Statin therapy: review of safety and potential side effects","volume":"32","author":"Ramkumar S","year":"2016","unstructured":"Ramkumar S, Raghunath A, Raghunath S. Statin therapy: review of safety and potential side effects. Acta Cardiol Sin. 2016, 32:631-9. 10.6515\/acs20160611a","journal-title":"Acta Cardiol Sin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4068\/cmj.2013.49.1.1","article-title":"Role of statins in coronary artery disease","volume":"49","author":"Lim SY","year":"2013","unstructured":"Lim SY. Role of statins in coronary artery disease. Chonnam Med J. 2013, 49:1-6. 10.4068\/cmj.2013.49.1.1","journal-title":"Chonnam Med J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2005.02355.x","article-title":"Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention","volume":"59","author":"Perreault S","year":"2005","unstructured":"Perreault S, Blais L, Lamarre D, et al.. Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention. Br J Clin Pharmacol. 2005, 59:564-73. 10.1111\/j.1365-2125.2005.02355.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.02.071","article-title":"Statin-associated side effects","volume":"67","author":"Thompson PD","year":"2016","unstructured":"Thompson PD, Panza G, Zaleski A, Taylor B. Statin-associated side effects. J Am Coll Cardiol. 2016, 67:2395-410. 10.1016\/j.jacc.2016.02.071","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen AL","year":"2011","unstructured":"Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR, Casciola-Rosen LA. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum. 2011, 63:713-21. 10.1002\/art.30156","journal-title":"Arthritis Rheum"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6660362","article-title":"Statin-induced triad of autoimmune myocarditis, myositis, and transaminitis","volume":"2021","author":"Ajmal M","year":"2021","unstructured":"Ajmal M, Singh A, Kubba S, Hershman M, Acharya T. Statin-induced triad of autoimmune myocarditis, myositis, and transaminitis. Case Rep Cardiol. 2021, 2021:6660362. 10.1155\/2021\/6660362","journal-title":"Case Rep Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-234805","article-title":"Severe statin-induced autoimmune myopathy successfully treated with intravenous immunoglobulin","volume":"13","author":"G\u00fcng\u00f6r C","year":"2020","unstructured":"G\u00fcng\u00f6r C, Wieshmann UC. Severe statin-induced autoimmune myopathy successfully treated with intravenous immunoglobulin. BMJ Case Rep. 2020, 13:e234805. 10.1136\/bcr-2020-234805","journal-title":"BMJ Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000497","article-title":"Statin-associated autoimmune myopathy: a systematic review of 100 cases","volume":"23","author":"Nazir S","year":"2017","unstructured":"Nazir S, Lohani S, Tachamo N, Poudel D, Donato A. Statin-associated autoimmune myopathy: a systematic review of 100 cases. J Clin Rheumatol. 2017, 23:149-54. 10.1097\/RHU.0000000000000497","journal-title":"J Clin Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.775749","article-title":"Could statin therapy be useful in patients with coronavirus disease 2019 (COVID-19)?","volume":"8","author":"Torres-Pe\u00f1a JD","year":"2021","unstructured":"Torres-Pe\u00f1a JD, Katsiki N, Perez-Martinez P. Could statin therapy be useful in patients with coronavirus disease 2019 (COVID-19)?. Front Cardiovasc Med. 2021, 8:775749. 10.3389\/fcvm.2021.775749","journal-title":"Front Cardiovasc Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2021.02.008","article-title":"Effects of statins on myocarditis: a review of underlying molecular mechanisms","volume":"67","author":"Parsamanesh N","year":"2021","unstructured":"Parsamanesh N, Karami-Zarandi M, Banach M, Penson PE, Sahebkar A. Effects of statins on myocarditis: a review of underlying molecular mechanisms. Prog Cardiovasc Dis. 2021, 67:53-64. 10.1016\/j.pcad.2021.02.008","journal-title":"Prog Cardiovasc Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/125238-statin-induced-myositis-with-concomitant-myocarditis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:43:26Z","timestamp":1707489806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/125238-statin-induced-myositis-with-concomitant-myocarditis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.31871","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,24]]}}}